Copyright
©The Author(s) 2023.
World J Clin Oncol. Jul 24, 2023; 14(7): 265-284
Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.265
Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.265
Figure 4 Study design for female to male gender affirming surgery patients.
FtM: Female to male; IDC: Invasive ductal carcinoma; DCIS: Ductal carcinoma in situ; AR: Androgen receptor.
- Citation: Panichella JC, Araya S, Nannapaneni S, Robinson SG, You S, Gubara SM, Gebreyesus MT, Webster T, Patel SA, Hamidian Jahromi A. Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery. World J Clin Oncol 2023; 14(7): 265-284
- URL: https://www.wjgnet.com/2218-4333/full/v14/i7/265.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i7.265